Adjuvant chemotherapy for stage C colonic cancer in a multidisciplinary setting

ANZ Journal of Surgery

Volumn 79, Issue 10, 2009, Pages 685-692

  Chapuis, Pierre H ^a   Bokey, E Leslie ^a   Clarke, Stephen ^b   Beale, Philip ^b   Dent, Owen F ^a  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Colonic cancer; adjuvant chemotherapy; Survival; Toxicity

Indexed keywords

FLUOROURACIL; FOLINIC ACID;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG DOSE REDUCTION; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; RISK FACTOR; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

AGED; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; COLECTOMY; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; NEOPLASM STAGING; NEW SOUTH WALES; PROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 70350482209     PISSN: 14451433     EISSN: 14452197     Source Type: Journal    
DOI: 10.1111/j.1445-2197.2009.05052.x     Document Type: Article

References (23)

1. Wieand HS, Leieh JE, Rubin J. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990 264 : 1444 1450.
2. Glimelius B, Dahl O, Cedermark B et al. Adjuvant chemotherapy in colorectal cancer: A joint analysis of randomised trails in the Nordic Gastrointestinal Tumour Adjuvant Therapy Group. Acta Oncol. 2005 44 : 904 912.
3. Wils J. Adjuvant treatment of colon cancer: past present and future. J. Chemother. 2007 19 : 115 122.
4. National Health and Medical Research Council. Guidelines for the Early Detection and Management of Colorectal Cancer (CRC). Canberra : NHMRC, 1999.
5. Armstrong K, O'Connell D, Leong D, Spigelman A, Armstrong B. The New South Wales Colorectal Cancer Care Survey 2000. Part 1. Surgical Management. Sydney : The Cancer Council NSW, 2004.
6. Nordman IC, Iyer S, Joshua AM, Clarke SJ. Advances in the adjuvant treatment of colorectal cancer. ANZ. J. Surg. 2006 76 : 373 380.
7. Chapuis PH, Dent OF, Bokey EL, Newland RC, Sinclair G. Adverse histopathological findings as a guide to patient management after curative resection of node-positive colonic cancer. Br. J. Surg. 2004 91 : 349 354.
8. McArdle CS, Hole D. Impact of variability among surgeons on postoperative morbidity and mortality and ultimate survival. BMJ 1991 302 : 1501 1505.
9. Barton M, Gabriel GS, Miles C. Colorectal cancer patterns of care in Western Sydney and Wentworth Area Health Services. ANZ J. Surg. 2004 74 : 406 412. (Pubitemid 38887829)
10. Morris M, Platell C, Fritschi L, Iacopetta B. Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients. Br. J. Cancer 2007 96 : 701 707.
11. Gibbs P, Handolias D, McLaughlin S, Chapman M, Johns J, Faragher I. Single-institution experience of adjuvant 5-fluoroucil-based chemotherapy for stage III colon cancer. Int. Med. J. 2008 38 : 265 269.
12. Newland RC, Chapuis PH, Pheils MT, Macpherson JG. The relationship of survival to staging and grading of colorectal carcinoma. A prospective study of 503 cases. Cancer 1981 47 : 1424 1429.
13. Newland RC, Chapuis PH, Smyth EJ. The prognostic value of substaging in colorectal carcinoma. A prospective study of 1117 cases with standardized pathology. Cancer 1987 60 : 852 857.
14. Bokey EL, Chapuis PH, Dent OF, Mander MD, Bissett IP, Newland RC. Surgical technique and survival in patients having a curative resection for colon cancer. Dis. Colon Rectum 2003 46 : 860 866.
15. Rickard MJFX, Dent OF, Sinclair G, Chapuis PH, Bokey EL. Background and perioperative risk factors for prolonged hospital stay after resection of colorectal cancer. ANZ J. Surg. 2004 74 : 4 9.
16. Tytherleigh MG, Bokey EL, Chapuis PH, Dent OF. Is a minor clinical leak clinically significant after resection of colorectal cancer? J. Am. Coll. Surg. 2007 205 : 648 653.
17. Davis NC, Newland RC. Terminology and classification of colorectal adenocarcinoma: the Australian Clinico-Pathological Staging System. ANZ J. Surg. 1983 53 : 211 221.
18. Fielding LP, Arsenault PA, Chapuis PH et al. Clinicopathological staging for colorectal cancer: an International Documentation (IDS) and an International Comprehensive Anatomical Terminology (ICAT). J. Gastroenterol. Hepatol. 1991 6 : 325 344.
19. Poon MA, O'Connell MJ, Moertel CG et al. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. J. Clin. Oncol. 1989 10 : 1407 1418.
20. Petrelli N, Douglass HO Jr., Herrera L et al. The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group. J. Clin. Oncol. 1989 10 : 1419 1426.
21. Hershman D, Hall MJ, Wang X et al. Timing of adjuvant chemotherapy initiation for stage III colon cancer. Cancer 2006 11 : 2581 2588. (Pubitemid 44845611)
22. Dobie SA, Baldwin L-M, Dominitz JA, Matthews B, Billingsley K, Barlow W. Completion of therapy by medicare patients with stage III colon cancer. J. Natl. Cancer Inst. 2006 98 : 610 619.
23. Neugut AI, Matasar M, Wang X et al. Duration of adjuvant chemotherapy for colon cancer and survival among the elderly. J. Clin. Oncol 2006 24 : 2368 2375. (Pubitemid 46630669)